4//SEC Filing
Hoekman John 4
Accession 0001209191-23-010247
CIK 0001445499other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 6:22 PM ET
Size
5.6 KB
Accession
0001209191-23-010247
Insider Transaction Report
Form 4
Hoekman John
Chief Scientific Officer
Transactions
- Award
Stock Option (right to buy)
2023-02-14+42,500→ 42,500 totalExercise: $2.29Exp: 2033-02-13→ Common Stock (42,500 underlying)
Footnotes (1)
- [F1]The option vests as to 2.0833% of the total shares on March 14, 2023 and then 2.0833% of the total shares vests monthly thereafter, with 100% of the total shares vested and exercisable on February 14, 2027, subject to the reporting person's provision of service to the issuer on each vesting date.
Documents
Issuer
IMPEL PHARMACEUTICALS INC
CIK 0001445499
Entity typeother
Related Parties
1- filerCIK 0001855676
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 6:22 PM ET
- Size
- 5.6 KB